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Edited by Ned ManteiAbstract Engrailed-2 (En-2) belongs to an evolutionarily
conserved family of DNA binding homeodomain-containing
proteins that are expressed in mammalian brain during develop-
ment. Here, we demonstrate that serine 267 in the homeodomain
of En-2 is phosphorylated by protein kinase A (PKA) in
forskolin-treated COS-7 cells. Furthermore, we analyze the
physiological function of En-2 phosphorylation by PKA. The
nuclear localization of En-2 is not inﬂuenced by the phosphor-
ylation of serine 267. However, substitution of serine 267 with
alanine resulted in increased binding of En-2 to DNA, while
replacing serine 267 with glutamic acid resulted in decreased
En-2 DNA binding. These results suggest that the transcriptional
activity of En-2 is regulated by PKA.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Homeodomain proteins are a large evolutionarily conserved
family of transcription factors that share a common 60 amino
acid DNA binding domain referred to as the homeodomain.
These proteins regulate gene expression of speciﬁc target genes
involved in regulation of major developmental patterning
events [1]. The protein encoded by the engrailed gene contains
a homeodomain, has sequence speciﬁc DNA binding activity,
and functions as a transcriptional repressor [2–4]. Vertebrates
have two engrailed genes that encode two homologous pro-
teins referred to as engrailed-1 (En-1) and engrailed-2 (En-2)
[5]. During brain development En-1 and En-2 are expressed in
the midbrain and cerebellum in a spatially and temporally
restricted manner [6,7].
Homeodomain proteins bind short A/T-rich consensus
sequences often with an ATTA core motif [8]. Because these
motifs are abundant in eukaryotic genomes, the DNA
sequence speciﬁcity of the homeodomain is relatively low [9].
Hence, the speciﬁcity of the homeodomain proteins is regu-* Corresponding author. Fax: +45-43-23-39-29.
E-mail address: mh@dcb-glostrup.dk (M. Hjerrild).
Abbreviations: DTT, dithiotreitol; En-2, engrailed-2; HA-tag, haemag-
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post-translational modiﬁcations [10]. Protein phosphorylation
and dephosphorylation is a widely described regulation pro-
cess aﬀecting structure, subcellular localization and DNA
binding of transcription factors [11].
It has previously been demonstrated that engrailed proteins
are phosphoproteins [12]. Protein kinase CK2 phosphorylates
engrailed protein outside the homeodomain leading to en-
hanced DNA binding [13]. Furthermore, a serine-rich domain
within En-2 (amino acids 146–169) is phosphorylated by pro-
tein kinase CK2 resulting in regulation of transfer of En-2
between cells [14]. We have recently identiﬁed En-2 as an in
vitro substrate of protein kinase A (PKA) and determined
serine 267 as an in vitro phosphoacceptor site [31]. In the
present study, we have demonstrated that serine 267 is also
phosphorylated in vivo by PKA in forskolin treated COS-7
cells transfected with En-2. We analyzed the putative physio-
logical functions of the PKA-mediated En-2 phosphorylation
and observed that the subcellular localization of En-2 was not
aﬀected by phosphorylation. However, replacement of serine
267 with glutamic acid mimicking phosphoserine leads to
reduced DNA binding, while replacement of serine 267 with
alanine removing the phosphorylation site leads to increased
DNA binding. These results indicate that En-2 interaction with
DNA promoters is regulated by PKA phosphorylation.2. Materials and methods
2.1. Plasmid constructs
Plasmid encoding murine En-2 was generously given by Alexandra
Joyner, Department of Cell Biology, New York University School of
Medicine, New York, USA [5]. En-2 was sub-cloned into a pMT2-
MCS vector using SalI and BsiWI cloning sites to generate an
expression construct encoding N-terminally haemagglutinin (HA)-
tagged En-2. Serine 267 was substituted with alanine or glutamic acid
using the QuickChangeTM procedure (Stratagene, www.strata-
gene.com).
2.2. Cell culture and transfection
COS-7 cells were grown in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum and antibiotics. Cells were
incubated at 37 C in a humidiﬁed atmosphere containing 5% CO2.
Plasmid encoding HA-tagged En-2 was transfected into COS-7 cells
using LipofectamineTM Reagent (In Vitrogen, www.invitrogen.com)
according to the protocol of the manufacturer and the cells were
harvested after 48 h. For in vivo PKA studies, cells were grown 16 h
without serum after which cells were either stimulated or not by adding
forskolin to a ﬁnal concentration of 50 lM (Sigma–Aldrich,
www.sigma-aldrich.com) for 20 min prior to harvesting cells.ation of European Biochemical Societies.
Fig. 1. In vitro phosphorylation of En-2 by the catalytic subunit of
PKA. COS-7 cells were transfected with plasmids encoding HA-tagged
wild type En-2 and mutant En-2 S267A. After 48 h the cells were lysed
and En-2 was immunoprecipitated from the cell lysates with antibody
against the HA-tag. The immunoprecipitated proteins were phos-
phorylated by the catalytic subunit of PKA with [c-32P]ATP. A:
Coomassie blue staining of wild type En-2 and mutant En-2 S267A
after in vitro phosphorylation and SDS–PAGE. B: The phosphory-
lated proteins were detected by autoradiography. C: Quantiﬁcation of
the 32P-labeled phosphate incorporated into wild type En-2 and mu-
tant En-2 S267A.
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COS-7 cells were lysed in lysis buﬀer (150 mM NaCl, 50 mM Tris–
HCl, 0.5% Triton X-100, 5 mM EDTA, 1 mM Na3VO4, 50 mM NaF,
10 mMNa-b-glycerophosphate, 1 mM PMSF, 10 nM calyculin, 10 lM
leupeptin, 5 lM pepstatin and 1000 U/ml aprotinin) at 4 C for 15 min.
The lysate was centrifuged at 4 C for 15 min at 10 000· g and the
resulting supernatant was incubated for 2 h at 4 C with monoclonal
12CA5 HA antibody. Anti-HA-tag antibody was prepared from the
12CA5 mouse hybridoma cell line. Protein G–Sepharose beads were
added to the immune complexes and the mixture was incubated for 30
min at 4 C. The immunoprecipitated complexes were subsequently
washed three times with lysis buﬀer and twice with 1.5 kinase buﬀer
(45 mM Tris–HCl, 15 mM MgCl2 and 1.5 mM dithiotreitol, DTT).
2.4. In vitro PKA kinase assay
Prior to PKA assay En-2 was incubated with alkaline phosphatase
(New England Biolabs, www.neb.com) at 37 C for 30 min to remove
phosphorylated residues and washed three times with kinase buﬀer.
En-2 was incubated with or without 10 U of PKA catalytic subunit
(Sigma–Aldrich), 20 lM ATP, 0.5 ll [c-32P]ATP (10 mCi/ml), 30 mM
Tris–HCl, 10 mM MgCl2 and 1 mM DTT at 30 C for 20 min. The
resins were washed twice with 1.5· kinase buﬀer to remove excess
[c-32P]ATP. Reactions were stopped by the addition of 20 ll 1
Laemmli sample buﬀer prior to separating proteins by SDS–PAGE.
Finally, phosphorylated protein bands were visualized by autoradi-
ography.
2.5. In-gel digestion
HA-tagged En-2 was excised from Coomassie stained gels. The
protein was reduced with 10 mM DTT at 56 C for 45 min and sub-
sequently alkylated with 55 mM iodoacetamide at room temperature
for 30 min [15]. The proteins were digested overnight at 37 C with an
excess of sequencing grade trypsin (Promega, www.promega.com).
Peptides were extracted from the gel by addition of 5% formic acid and
acetonitrile. The resulting supernatant was subsequently lyophilized
and resuspended in 20 ll of 5% formic acid.
2.6. Peptide sequencing by tandem mass spectrometry
Automated nanoﬂow liquid chromatography electrospray tandem
mass spectrometric (LC-ESI-MS/MS) analysis was performed using a
quadrupole time-of-ﬂight Ultima mass spectrometer (Waters/Micro-
mass, www.waters.com). A nano-HPLC system (Ultimate; www.
lcpackings.com) delivering a ﬂow of 175 nl/min was used to separate
the peptide mixture prior to mass spectrometry analysis. Five ll of
peptide sample was loaded on the column (Agilent Zorbax SB-C18 3.5
lm; 50 lm internal diameter) using a high-pressure vessel (Proxeon
Biosystems, Odense, Denmark) and separated using a gradient of 5–
38% acetonitrile in 30 min. The data were analyzed by MassLynx
software and the Mascot search engine (www.matrixsciences.com).
2.7. Immunoblotting
Immunoblotting was performed as previously described [16]. Brieﬂy,
proteins were separated by SDS–PAGE and HA-tagged En-2 was
detected by immunoblotting using an antibody against the HA-tag
(rabbit polyclonal HA probe Y-11, Santa Cruz Biotechnology,
www.scbt.com). The purity of isolated nuclei was analyzed by immu-
noblotting using a cytoplasmic marker b-actin (Sigma–Aldrich) and a
nuclear marker Rb-1 (Abcam, www.abcam.com).
2.8. Isolation of nuclei
Nuclei were isolated from COS-7 cell expressing wild type or mutant
En-2 using the Nuclei EZ PREP kitTM (Sigma–Aldrich) as described
by the manufacturer. Nuclei were resuspended in 100 ll 1· Laemmli
sample buﬀer, the proteins were separated by SDS–PAGE and HA-
tagged En-2 was immunoblotted using a polyclonal antibody against
HA (Y-11).
2.9. DNA binding assay
COS-7 cell extracts were prepared in 400 ll extraction buﬀer (20 mM
HEPES, pH 7.8, 450 mM NaCl, 0.4 mM EDTA, 0.5 mM DTT, 25%
glycerol, and 1 mM PMSF) by freezing and thawing three times fol-
lowed by centrifugation at 16 000· g for 10 min. 30 pmol of each oligo
(Fig. 4A) was labeled using T4 polynucleotide kinase and [c-32P]ATP.
Oligos were combined and annealed by heating to 100 C followed by
slow cooling to 37 C. The radioactively labeled double stranded oligoswere puriﬁed using MicroSpinTM G-25 columns (Amersham Bio-
sciences, www.amersham.com). 3 ll cell extract, 10 ll binding buﬀer
(20 mM HEPES, pH 7.9, 1 mM MgCl2, 4% Ficoll, and 0.5 mM DTT)
and 1 lg dI–dC were pre-incubated at room temperature for 15 min. 1
ll probe was added and the reaction was incubated for further 25 min.
Complexes were loaded onto a 5% (29:1 (w/v) acrylamide, N ;N 0-
methylenebisacrylamide) non-denaturing 0.5· TBE (90 mM Tris, 90
mM borate, and 2 mM EDTA) polyacrylamide gel. Supershift analysis
was performed using 12CA5 antibody against the HA-tag.3. Results and discussion
3.1. Serine 267 is the major in vitro PKA phosphorylation site in
En-2
We have previously identiﬁed serine 267 in mouse En-2 as a
PKA phosphorylation site in vitro [31]. To conﬁrm that PKA
phosphorylates serine 267, we made mutant En-2 S267A. Wild
type En-2 and mutant En-2 S267A were transfected into COS-
7 cells and the proteins were immunoprecipitated using an
antibody against the HA-tag. Immunoprecipitated proteins
were incubated with puriﬁed catalytic subunit of PKA in the
presence of [c-32P]ATP. The phosphorylated proteins were
resolved by SDS–PAGE, stained with Coomassie blue
(Fig. 1A) and phosphorylation was detected by autoradiog-
raphy (Fig. 1B). The amount of incorporated phosphate was
quantiﬁed by scintillation counting (Fig. 1C). The amount of
incorporated phosphate into En-2 by PKA decreased to 20%
when serine 267 was substituted with alanine. This conﬁrms
that the major in vitro PKA phosphorylation site in En-2 is
serine 267.
3.2. Identiﬁcation of in vivo phosphorylation sites in En-2
In the present study, we analyzed whether serine 267 phos-
phorylated by PKA in vitro is also modiﬁed by PKA in vivo.
PKA is activated by increased cAMP concentration, generated
through adenylate cyclase as a response to the activation of G
protein-coupled receptors [17]. Forskolin is known to stimulate
adenylate cyclase. COS-7 cells were transfected with a construct
encoding HA-tagged En-2 and cells were serum starved prior to
treatment with forskolin. HA-tagged En-2 was immunopre-
Fig. 3. Subcellular distribution of En-2. A: Amino acid sequence 267–
280 between a-helix 2 and 3 in En-2. The nuclear export sequence is
underlined. B: COS-7 cells were transfected with HA-tagged wild type
En-2 or mutant En-2 S267A or S267E followed by incubation in the
absence or presence of 50 lM forskolin for 20 min. After lysis of cells,
the nuclei were isolated and the proteins in lysate and nuclei separated
by SDS–PAGE. En-2 in lysate and nuclear fraction was determined
by immunoblotting using an antibody against the HA-tag. C: Im-
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Automated nanoﬂow LC-ESI-MS/MS was performed to locate
speciﬁc serine or threonine phosphorylation site(s) in En-2.
Peptide fragment ions of the b- and y-type [18] allowed exact
localization of phosphorylation sites. b-Elimination of phos-
phoric acid and conversion of phosphoserine to dehydroala-
nine acid conﬁrmed the phosphoamino acid assignments. This
analysis revealed that En-2 was phosphorylated at serine 32 in
serum-starved cells and that serine 32 and serine 267 were
phosphorylated in forskolin-treated cells. Hence, we conclude
that En-2 is phosphorylated by PKA at serine 267 in cultured
COS-7 cells. This conﬁrms our previous observation that serine
267, but not serine 32 is phosphorylated by PKA in vitro. Serine
32 is followed by a proline and this site may likely be phos-
phorylated by a proline-directed protein kinase under basal
conditions (see Fig. 2).
3.3. PKA-mediated En-2 phosphorylation does not aﬀect the
nuclear localization of En-2
In accordance with the role of En-2 as a transcriptional
regulator, it is predominantly localized in the cell nucleus.
However, it has been reported that a 11 amino acids nuclear
export sequence (250–261) between a helix 2 and 3 of the
homeodomain is suﬃcient and necessary for nuclear export of
En-2 [19] (Fig. 3A). Since serine 267 is localized close to the
nuclear export sequence, we analyzed whether PKA-mediatedFig. 2. Identiﬁcation of in vivo PKA phosphorylation site in En-2.
Serum starved COS-7 cells expressing HA-tagged wild type En-2 were
treated with 50 lM forskolin for 20 min. After lysis of cells En-2 was
immunoprecipitated from the cell lysates with antibody against the
HA-tag and isolated by SDS–PAGE. The band containing En-2 was
excised from the gel and digested by trypsin. Tryptic peptides were
extracted from the gel and analyzed by LC-ESI-MS/MS. A: A doubly
charged phosphopeptide was detected carrying one phosphate group
(m=z 963.1). B: The fragment ions generated by LC-ESI-MS/MS
analysis showed that Ser-267 was phosphorylated in forskolin treated
cells. The fragmentation pattern of the peptide is indicated (only b and
y ions are indicated for simplicity). Ions labeled with an asterisk were
generated from the peptide in which the phosphoserine had been
converted to dehydroalanine by b-elimination (loss of phosphoric
acid¼ 98 Da).
munoblotting using antibodies against a cytoplasmic marker (b-actin)
and a nuclear marker (Rb-1) was used to demonstrate the eﬀective-
ness of the nuclear isolation. Cyt. is the cytoplasmic fraction and Nuc.
is the nuclear fraction.phosphorylation could have an eﬀect on the subcellular lo-
calization of En-2. COS-7 cells were transiently transfected
with constructs encoding wild type En-2, S267A or S267E
mutants. Forty-eight hours after transfection, the subcellular
localization of En-2 was analyzed directly by isolation of
nuclei followed by immunoblotting using an antibody against
the HA-tag (Fig. 3B). The total cellular expression of En-2 and
the S267A and S267E mutants was identical. The nuclear
localization of En-2 was not aﬀected by forskolin-treatment.
Furthermore, substituting serine 267 with alanine or glutamic
acid did not have any impact on nuclear localization. We
conclude that PKA-mediated En-2 phosphorylation does not
inﬂuence the nuclear localization of En-2. In addition, we
analyzed the puriﬁcation of isolated nuclei by immunoblotting
using antibodies against b-actin (cytoplasmic marker) and
Rb-1 (nuclear marker). Fig. 3C shows that the nuclear fraction
is contaminated by cytoplasmic b-actin to a low extent.
3.4. PKA-mediated En-2 phosphorylation aﬀects the DNA
binding
There are several examples of PKA-mediated protein phos-
phorylation modifying the DNA binding activity of transcrip-
tion factors either positively or negatively [20–22]. To determine
whether phosphorylation of En-2 protein could aﬀect the func-
tion ofEn-2 as a transcription factor,we tested theDNAbinding
aﬃnity of wild type En-2 and S267A and S267E mutants by gel
retardation assay using oligonucleotides containing two binding
sites for En-2 (Fig. 4A). As shown in Fig. 4B, the intensity of the
complexes formed with the S267A mutant was increased when
compared to the intensity of corresponding complexes formed
withwild typeEn-2. This result suggests that phosphorylation of
Fig. 4. DNA binding of En-2. A: Nucleotide sequence of the tandem
repeat double-stranded oligonucleotide used for gel mobility shift as-
say. B: COS-7 cells were transfected with empty pMT2 vector, wild
type En-2 or mutant En-2 S267A or S267E and lysed by freezing and
thawing three times. DNA binding assays were performed by incu-
bation of cell lysates with 32P-labeled oligonucleotide for 25 min at
room temperature. For gel supershift analysis 12CA5 antibody was
added to the samples. The protein–DNA complexes were analyzed by
non-denaturing PAGE. Positions of single-liganded and double-li-
ganded complexes are indicated as well as the supershift with 12CA5
antibody. C: Immunoblot showing the expression level of wild type
and mutant En-2 in COS-7 cell extract.
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containing medium leads to decreased DNA binding of En-2
compared to the S267Amutant. Serine 267 was also substituted
with a phosphoserinemimicking glutamic acid (S267E) [23]. The
S267Emutant showed less DNA binding activity than wild type
En-2. The expression of wild type and mutant En-2 was deter-
mined by Western blotting in Fig. 4C. Taken together these re-
sults indicate that En-2 phosphorylated at serine 267 has lower
DNA binding aﬃnity than the non-phosphorylated protein.
Furthermore, we analyzed if forskolin-treatment of COS-7,
HEK and SH-SY5Y cells transfected with wild type En-2 aﬀects
the DNA binding of En-2. However, we were not able to detect
reduced DNA binding of En-2 after forskolin-treatment of the
cells (data not shown). In addition, SDS–PAGEanalysis ofEn-2
immunoprecipitated from forskolin-treated cells did not show
any migration shift of En-2 compared with untreated cells. This
suggests that only a small fraction of En-2 is phosphorylated
after forskolin-treatment. However, changes in the activity of a
fraction of transcription factors could also be important for
cellular regulation.4. Conclusion
Diﬀerential gene expression regulated through speciﬁc
functions of transcription factors is important for cellular
diﬀerentiation. The function of transcription factors isdependent on nuclear localization, DNA binding and trans-
activation. The cAMP-dependent signaling pathway has long
been known to be involved in cell growth, diﬀerentiation and
cell-speciﬁc gene expression [24]. In addition, it has previously
been demonstrated that other homeodomain proteins are
phosphorylated within their homeodomain region [25–27].
Here, we show that serine 267 is the major PKA phosphory-
lation site in vivo after forskolin-treatment. This is in agree-
ment with our previous ﬁnding that En-2 is phosphorylated in
vitro by PKA [31]. Furthermore, we show that serine 267 is
important for the En-2 DNA binding. Replacing serine 267
with an alanine increases En-2 DNA binding in an electro-
phoretic mobility shift assay, while replacing serine 267 with a
phosphoserine mimicking glutamic acid results in decreased
DNA binding aﬃnity. However, understanding the role of
reduced DNA binding of phosphorylated En-2 in regulation of
cellular functions requires further study. The most conserved
function of En-2 seems to be its role in neuronal development.
Diﬀerentiation of neural progenitor cells is regulated by a
coordinate change in the expression of speciﬁc target genes
involved in diﬀerent intracellular signaling pathways. PKA
signaling has also been shown to be involved in neuronal dif-
ferentiation during brain development [28]. PKA phosphory-
lates CRE binding protein leading to regulation of neuronal
diﬀerentiation, neurite outgrowth and neuronal plasticity
[29,30]. We suggest that PKA-mediated phosphorylation of
serine 267 in En-2 could be part of the complex regulation of
neuronal development.
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